Document is current
Any future updates will be listed below
-
Authors
Staudacher, Dawid Leander
Heine, Laura
Maier, Alexander
Kaier, Klaus
Heidenreich, Adrian
Rilinger, Jonathan
Rottmann, Felix Arne
Biever, Paul Marc
Supady, Alexander
Wengenmayer, Tobias
Westermann, Dirk
Jäckel, Markus https://orcid.org/0000-0001-8638-5228
-
Funding
Funding for this research was provided by:
Universitätsklinikum Freiburg
- License Information
-
More Information
Article History
Received: 21 August 2024
Accepted: 30 October 2024
First Online: 18 November 2024
Declarations
:
: Dirk Westermann received fees from Abiomebd, AstraZeneca, Bayer, BoehringerIngelheim, Berlin-Chemie, Edwards Lifescience, Medtronic, and Novartis, independent from this work. Jonathan Rilinger received speaker’s honoraria from Astrazeneca and research grants from Abbott and Philips, independent from this work. AM was funded by the Berta-Ottenstein-Program for Advanced Clinician Scientists, Faculty of Medicine, University of Freiburg. All other authors declare that they have no competing interests.
: This retrospective study was approved by the ethics committee of the Albert Ludwigs University of Freiburg, file number 387/19.
: Not applicable.
